US 7862821
Recombinant vaccine against bluetongue virus
granted A61KA61K2039/5256A61P
Quick answer
US patent 7862821 (Recombinant vaccine against bluetongue virus) held by The Regents of the University of California expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/5256, A61P, A61P31/04, A61P31/14